Evidence map›Paper›PMID 36971557›Full record

ReviewmBio2023

Bacterial Type II Secretion System and Its Mitochondrial Counterpart.

Anna Shaliutina-Loginova, Olivera Francetic, Pavel Doležal

Abstract readReview
In one paragraph

Review in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Antibiotic resistance inFrontiers in microbiology · 2026
    Review
  6. Article
  7. Molecular evolution and adaptations ofFrontiers in cellular and infection microbiology · 2026
    Review
  8. Review
  9. An essential and highly selective protein import pathway encoded by nucleus-forming phage.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna Shaliutina-LoginovaDepartment of Parasitology, Faculty of Science, BIOCEV, Charles University, Vestec, Czech Republic.
Olivera FranceticInstitut Pasteur, Université Paris Cité, Biochemistry of Macromolecular Interactions Unit, Department of Structural Biology and Chemistry, CNRS UMR 3528, Paris, France.
Pavel DoležalDepartment of Parasitology, Faculty of Science, BIOCEV, Charles University, Vestec, Czech Republic.ORCID 0000-0003-1285-9026

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the billions of years that bacteria have been around, they have evolved several sophisticated protein secretion nanomachines to deliver toxins, hydrolytic enzymes, and effector proteins into their environments. Of these, the type II secretion system (T2SS) is used by Gram-negative bacteria to export a wide range of folded proteins from the periplasm across the outer membrane. Recent findings have demonstrated that components of the T2SS are localized in mitochondria of some eukaryotic lineages, and their behavior is consistent with the presence of a mitochondrial T2SS-derived system (miT2SS). This review focuses on recent advances in the field and discusses open questions concerning the function and evolution of miT2SSs.

Indexed as

Type II Secretion SystemsBacterial ProteinsBacterial Secretion SystemsGram-Negative BacteriaPeriplasmBacterial ProteinsBacterial Secretion SystemsType II Secretion Systemsevolutionmitochondriamitochondrial evolutionprotein secretionprotein transportT2SStype II secretion system

Identifiers

PMID36971557
PMCPMC10128026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.